ONCASPAR
Powder for solution for injection/infusion, 750j./ml
RxActive license
Active substance (INN)
pegaspargase
Pharmaceutical form
Pharmaceutical formPowder for solution for injection/infusion
Strength750j./ml
PackagingUkupno 1 bočica staklena sa praškom za rastvor za injekciju/infuziju u kartonskoj kutiji
ManufacturerLes Laboratoires Servier Industrie, France
Therapeutic groupAntineoplastic and immunomodulating agents (L01XX24)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 14, 2022
Source: CInMED register